LaVoieHealthScience Honored with Silver Bell Ringer Award for Investor/Financial Relations Campaign

Campaign Optimized On-Message Coverage of Pivotal Phase 3 Data

BOSTON, MA – June 14, 2018 – LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, announced today it has won a Silver Bell Ringer Award in the Investor/Financial Relations Campaign category from the Publicity Club of New England for the agency’s work on behalf of its client, Ampio Pharmaceuticals (NYSE MKT: AMPE), a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.

LaVoieHealthScience developed an Investor/Financial Relations strategic communications campaign to ensure on-message visibility for Ampio’s announcement of pivotal data for Ampion™ for the treatment of osteoarthritis of the knee.

The LHS strategy was to develop a “surround sound” investor/financial relations communication plan. The plan used traditional, paid and social media, and was designed to reach all stakeholders with concise and compelling messaging for potential patients; therapeutic for physicians; scientific for KOLs; business oriented for strategic partners; and market-centric for investors.  “I want to thank our talented team and our client, Ampio for their specialized thinking and spot-on execution on this important investor communications program.  We are honored to be recognized again in 2018 by the Publicity Club of New England,” stated Donna L. LaVoie, President and CEO.

Since 1969, the Publicity Club of New England’s Bell Ringer Awards have been a symbol of outstanding achievement for New England public relations and communications professionals in every field and industry and across all forms of media.

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received over 30 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Affimed, BioAxone BioSciences, Biotechnology Innovation Organization, Fusion Pharmaceuticals, Genosco, Landos Biopharma, LEO Science Hub, Life Sciences Corridor, NewLink Genetics, Newron Pharmaceuticals, Origenis GmbH, PathMaker Biosystems, Scioto Biosciences, Symbiotix, Triumvira Immunologics, Xontogeny LLC, XenoTherapeutics and other emerging health and science companies.

###

Media Contact:
Katie Gallagher
Account Manager, PR and Marketing
kgallagher@lavoiehealthscience.com
617-374-8800 x109

LaVoieHealthScience to Co-Host the Writing for PR and Corporate Communications Conference

LaVoieHealthScience an integrated investor and public relations agency focused on advancing health and science innovations, today announced the agency will co-host The Writing for PR and Corporate Communications Conference with McDermott, Will & Emery taking place on August 1 – 2, 2018 in Boston, MA. Register for this event today!

This conference will help guide your writing, harness your corporate story, strike a chord with your stakeholders and increase your media pitch success rate. Over the two days you will attend sessions hosted by members of The New York Times, Cape Cod Healthcare and Dell Technologies to name a few. These sessions are intended to help those whose responsibilities include: writing and editing, corporate communications, public relations, internal communications, corporate storytelling, intranets, marketing and content creation.

Sample sessions include:

  • Creating (and delivering) an integrated message through executive communications
  • Secrets of success: Apply real-world tools to drive clicks, traffic and ROI
  • Audience first: Answering ‘What’s in it for me?’ in internal and external messaging
  • Pitch tank: Pitch our panel of journalists and see if your story sinks or swims

This conference offers exhibitor booths, speaking sessions, pre-conference workshop sessions, networking lunches, one-on-one meetings, marketing collateral and on-site branding and much more. It will be held at McDermott Will & Emery LLP at 28 State Street, Boston, MA.

Donna L. LaVoie to Deliver Workshop at BIO International Convention

How to Tell Your Company Story in Just 15 Slides

LaVoieHealthScience an integrated investor and public relations agency focused on advancing health and science innovations, today announced that Donna L. LaVoie, President and CEO, will be presenting at the BIO International Convention 2018 in Boston on Monday, June 4 at 1:00-2:15pm EST, in room 251, just before partnering opens.

The workshop, “How to Create Your Company Presentation in Just 15 Slides,” is based on the LHS trademarked process of your company’s story in just fifteen slides. This workshop will provide real time examples to fine-tune your presentation and pitch before you present your company story. The agency’s management team is also available for meetings through the BIO partnering portal.

“It’s exciting to be back, especially in our hometown in the “State of Possible,” where we have more innovation than anywhere in the world. I am honored to have been selected again this year by the 2018 BIO selection committee,” LaVoie said. “The market for “mindshare” is very competitive and it is very important for companies to create a clear and differentiated message in a fast-paced market of innovative technologies and medicine. It’s not enough to share data, companies need to tell stories within the boundaries of compliance rules.”

Hosted by Biotechnology Innovation Organization (BIO), BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

LaVoieHealthScience Adds Senior Financial Communications Practitioner

Paul Sagan joins LHS as AVP Investor Relations and Corporate Communications

LaVoie HealthScience, an integrated investor and public relations agency focused on advancing health and science innovations, today announced the continued expansion of its strategic communications team with the hiring of Paul Sagan, who is joining LHS as Assistant Vice President, Investor Relations and Corporate Communications, effective today. Paul joins LHS from KCSA Strategic Communications, where he was Vice President, Corporate Communications & Investor Relations and worked with a variety of health, science and technology-based clients.

Paul has more than 20 of experience in counselling both privately-held as well as publicly-held companies on investor relations, corporate and marketing communications matters and has served as an executive with several leading Wall Street and New

England-based consultancies, including senior financial communications positions at Sharon Merrill Associates, Morgan-Walke Associates, Thermo Electron Corporation, Allmerica Financial and Camp Dresser & McKee.

Skilled at communicating complex information about his life science clients to both the investment community and to the general public, Paul has advised more than 50 companies – from venture-backed startups to multi-national corporations.

“I’m excited to join LaVoieHealthScience, whose focus on integrated communications and domain expertise in the life sciences is unique,” said Paul. “The firm’s multi-disciplinary approach to IR, corporate communications and financial media relations has helped companies further their growth trajectory. I look forward to helping our clients – some of the luminaries in the life science field – achieve increased value for their innovations.”

As a member of the Senior Leadership Team at LHS, Paul will work with the practice leads in investor and public relations and support the respective practices and clients at the intersection of Science, Healthcare and Technology. Paul will also work as an advocate and facilitator of organizational growth for the firm.

Donna L. LaVoie, President & CEO commented, “With our keen focus on aligning with health, science and technology innovators, Paul’s expertise in strategic positioning and his relationships with institutional investors, analysts, and the media will be important to our firm’s continued success. Paul’s broad experience will be a strong addition to our existing team and an asset to our current and future clients.”

Donna LaVoie, President and CEO of LaVoieHealthScience, Announced as Spokeies Award Winner in two Categories

The SPOKEies® are the first awards program to honor the best in-house spokespeople representing brands, non-profits and corporations. The mission behind the SPOKEies® is to acknowledge and reward leaders who communicate honestly and effectively on behalf of their organizations. The winners were judged based on their ability to achieve organizational goals, creativity, trust and authenticity as a spokesperson.

The winners share their advice with the communications community on May 3, 2018 on a live multi-channel video stream called “Spokesperson Secrets to Build Your Brand.” A full list of honorees can be found on this Awards Page which also includes quotes and tips from the winners.

Donna has been recognized as the winner of the “Corporate Emerging Growth/Startups” and “C-Suite Leader Corporate” categories.

LaVoieHealthScience Presents How to Engage Busy Biotech Reporters

This not-to-be-missed Q&A panel, moderated by Donna LaVoie, Founder and CEO of LaVoieHealthScience, will feature top reporters and editors discussing paid, earned and online coverage of today’s health and science scene, including:

  • Gideon Gil, Managing Editor, STAT
  • Lisa Henderson, Group Editorial Director, Applied Clinical Trials and Pharmaceutical Executive
  • Lisa LaMotta, Senior Editor, BioPharma Dive
  • Angus Macaulay, Chief Revenue Officer, STAT
  • Max Stendahl, Biotech Reporter, Boston Business Journal

What You’ll Hear:

  • What top reporters are covering
  • The Good, The Bad & The Ugly of pitches they receive every day
  • Anatomy of a winning pitch
  • How to establish a relationship based on mutual value
  • Creative ways to engage beyond traditional coverage
  • Pros & cons of paid versus earned, shared media

Travel Coordinates:

  • Parking garage located at 800 Technology Square, Cambridge, MA 02139
  • T Stop: Kendall Square, Red Line is approximately 2 blocks away

Where?

The Collaboration Room at MassBio, 300 Technology Square, 8th Floor, Cambridge, MA 02139

When?

Friday, April 27, 2018. | 9:00 – 10:30 AM

RSVP

There is limited space, RSVP HERE today!

The Power of Mentorship: My Story on The Business of Health and Science

The Power of Mentorship: My Story on The Business of Health and Science

 

Wednesday, February 28th was an important day in the history of the biotechnology industry. It was #RareDiseaseDay and Henri Termeer’s birthday. It was also a day to remember the #biotech pioneers who helped to transform #KendallSquare into a global #lifescience hub in #Cambridge.

It was with great respect that I attended the dedication ceremony Wednesday in Henri’s honor to rename the Kendall Square North Plaza “Henri A. Termeer Square.” I am proud to be part of this community and team of amazing people.

My memories of the early days at @SanofiGenzyme (formerly Genzyme) when I worked with Henri and the founding management team are vast and deep. Henri had many talents but one key one was his ability to bring people together for the benefit of a cause – in this case for patients. He and the management team at @Genzyme pushed things forward with tremendous force to create an industry of #innovation, especially New England region. He said yes when others said no. And, he kept searching for answers to questions to create major advances in how patients are treated with rare diseases.

Henri was the person who encouraged me to become a storyteller in our industry — to be counted for what I believed in and to push for answers to questions. He also told me that I would have my own firm one day. And, here we are @LaVoieHealthScience in our 17th year in business serving health and science companies around the globe with specialized thinking in strategic communications. 

It’s life’s mentors that impact who you are and what you become, and I am thankful for the inspiration he and others gave me as we continue with passion for this amazing field. Wishing you the same.

Xontogeny’s Biotech Entrepreneur Webinar Series

Title:  Xconomy Insight & Xontogeny present: Starting a Biotech Company: Where to Begin

Day/Date/Time: Wednesday, March 7, 1:00 – 2:00 pm EST

Description: Launching a biotech company is a daunting task. It takes conviction, passion, and an idea or technology that offers a clear path from science to a valuable asset that will attract investors. So how do you know if you have a great idea? Once you have formulated a narrative around the concept, where and how do you begin to create a company? What are the key steps to take – and the potential mistakes that you need to avoid? What are the tradeoffs in creating a virtual company with a lean staff versus a broader team to support the organizational needs?

This webinar will draw on years of experience from legal, seed investors, and tech transfer experts to explore these questions. These panelists will discuss the best kind of structure for the company, where (and how) to begin looking for financial support, and how you can build a solid foundation for your biotech company. The webinar is designed to provide the basic knowledge and guidance that will give your nascent company the best chances for success.

Link to Registration:  https://event.on24.com/wcc/r/1589149/FF4262C8797CFF8267F5EFD1B8141CF4?partnerref=Xontogeny1

LaVoieHealthScience to Begin Working with Life Sciences Corridor

LaVoieHealthScience to Begin Working with Life Sciences Corridor

 

Competitive Contract Recognized LHS’ Health and Science Connectedness

 

Boston, MA – January 16, 2018 —  LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced engagement with the Life Sciences Corridor, a partnership among five Greater Boston cities including Boston, Braintree, Cambridge, Quincy and Somerville. LHS will leverage content and optimize social media channels on behalf of Life Sciences Corridor to ensure visibility for the Corridor’s unique offering of talent, facilities and connections for life science companies.

The Life Sciences Corridor is an initiative launched by the mayors of the five Greater Boston communities to promote the robust life sciences sector along the MBTA red line. Nicknamed “the brain train,” the cluster represents more than 460 companies within the life science industry sector. With the goal of attracting business from outside the region as well as retaining businesses within the region, the Corridor also promotes cross collaboration among universities, institutions and businesses.

“As contributors to the health and life science ecosystem in the Greater Boston Area, LHS welcomes the opportunity to work with an initiative whose mission includes helping companies understand the advantages and offerings of companies in the Corridor,” said Donna L. LaVoie, President and CEO of LaVoieHealthScience. “We have been aligned with leaders in the life science sector since its infancy more than 15 years ago and we look forward to connecting with the various companies and helping grow this already flourishing industry.”

“For years, Cambridge has been planning for new major economic development opportunities, including the Volpe Center and Cambridge Crossing projects, and we are looking forward to continuing our collaboration with Boston, Quincy, Somerville, and Braintree to support the life sciences industry in Massachusetts,” said Cambridge City Manager Louis A. DePasquale. “The partnership between the five cities of the Life Sciences Corridor is helping transform the regional economy by bolstering support for hundreds of life sciences companies.”

“Boston is home to a growing network of businesses, entrepreneurs, researchers, employees, and job seekers actively contributing to life saving technologies and innovation within the region’s life sciences cluster,” said John Barros, Chief of Economic Development in the City of Boston. “By collaborating with our neighboring cities, all connected by the Red Line of our transit system, we are leveraging shared resources to further position the Boston region as a global leader for the life sciences industry.”

“For anyone outside of Massachusetts seeking to grow their business, the Boston region has always been defined broadly, and this partnership will embrace that,” said Braintree Mayor Sullivan.

“It’s an opportunity that benefits everyone involved,” said Quincy Mayor Koch. “This partnership will capture the immediate impacts on business development and institutional growth.”

“It’s great to see these five cities working with a local agency that specializes in the life science field,” said Somerville Mayor Curtatone. “They understand not only the local ecosystem, but also how to target outside, national audiences to drive growth.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. LaVoieHealthScience represents other life science leaders such as Ampio Pharmaceuticals, Biotechnology Innovation Organization, Fusion Pharmaceuticals, Iota BioSciences, Landos Biopharma, LEO Science Hub, NewLink Genetics, Newron Pharmaceuticals, Oncocyte, Origenis, Savara, Xontogeny LLC and other emerging health and science companies. Follow LHS on Twitter at @LaVoieGroup.

Media Contact:
Beth Kurth
Vice President, Investor Relations
bkurth@lavoiehealthscience.com
617-374-8800 x106

 

Coordinating Messages When Companies Join Forces

Click the image to read more.

By Donna LaVoie

Life science companies, including big and small pharma, biotech and health technology, continue the trend toward partnerships to research, develop and/or commercialize their innovations, allowing companies to enter new markets, continue niche disease research and development and introduce innovations sooner. Adding to the mix are accelerators and venture firms launching new companies into the health science and technology ecosystem.

Even though they are joining forces, and likely have the same end-goal, each of these companies will have a unique, and sometimes competing, set of communications and business goals. They also may have different priorities on stakeholder mix. While it’s easy to default to the needs of the larger company, strategic communications entails finding ways to balance the needs of all parties in the transaction.

Read more at O’Dwyer’s.